Skip to content
TREVENTIS™ Corporation
  • Home
  • About Us
    • Board of Directors
    • Advisory Board
  • Pipeline
    • Dual Aβ/ tau oligomer inhibitor
    • Broad spectrum TDP oligomer inhibitor
    • p53 oligomer inhibitor
  • Technology
    • Protein Misfolding: The Basics
    • Treventis’ CCM Technology
  • Therapeutic Areas
    • Alzheimer’s Disease and Tauopathy
    • Amyotrophic Lateral Sclerosis (ALS)
    • Parkinson’s Disease
    • Cancer
  • News & Publications
    • News
    • Publications
    • Social Media
  • Careers
  • Partners & Collaborators
  • Contact Us
TREVENTIS™ Corporation
TREVENTISTM Corporation > News & Publications > News > Treventis Attending BIO 2022
  • Share
             
  • Print

Treventis Attending BIO 2022

BIO 2022

Treventis will be at BIO next week -in person! Please ping us if you would like to meet in person or virtually.

https://www.linkedin.com/in/chrisbarden/

Print

Post navigation

Treventis attends RESI Nov 2021
Dr. Donald Weaver, Oskar Fischer Prize Winner
  • News
  • Publications
  • Social Media

Quick Links

  • Home
  • About Us
  • Contact Us

Social Links

  • Twitter
  • Linkedin
Copyright © Treventis Corporation. | Site Map
Website by Axxiem